Shah Capital Responds to Significant Shareholder Dissent at Novavax AGMRALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, today commented on yesterday’s announced voting results from Novavax’s June 18th 2026 Annual Meeting of Stockholders.
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual MeetingHighlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value
Shah Capital nominates two highly qualified independent director candidates for NovavaxBelieves the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its share price
